Close Navigation
1,000 Earning Expiration Put Spreads Trade in EyePoint Pharmaceuticals, Inc.

1,000 Earning Expiration Put Spreads Trade in EyePoint Pharmaceuticals, Inc.

OptionWatch:

Posted October 1, 2025 at 11:45 am

Jeff Praissman
Interactive Brokers

This morning 1,000 November 21 ‘25 15/10 vertical put spreads traded in EyePoint Pharmaceuticals, Inc.  (Symbol EYPT) for $1.65. At the time of the trade EYPT was trading at $14.24. The spread is a 40 delta and is the equivalent of 40,000 shares of stock and was an opening trade since there was zero open interest in either strike this morning. The spread traded mid-market, so it is unclear whether it was bought or sold.

 EYPT is expected to release earnings on November 5th, so this is potentially earnings play since there is no weekly options in EYPT. Vertical spreads allow the trade to minimize risk by being long one strike and short another.

EYPT is currently trading at $13.99. EYPT has a 52-week high of $14.91 and a 52-week low of $3.91.

Source: IBKR TWS. Past performance is not indicative of future results Interested in learning more about options? Check out our Interactive Options Course

Join The Conversation

For specific platform feedback and suggestions, please submit it directly to our team using these instructions.

If you have an account-specific question or concern, please reach out to Client Services.

We encourage you to look through our FAQs before posting. Your question may already be covered!

Leave a Reply

Disclosure: Interactive Brokers

The analysis in this material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IBKR to buy, sell or hold such investments. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Interactive Brokers, its affiliates, or its employees.

Disclosure: Options Trading

Options involve risk and are not suitable for all investors. For information on the uses and risks of options, you can obtain a copy of the Options Clearing Corporation risk disclosure document titled Characteristics and Risks of Standardized Options by going to the following link ibkr.com/occ. Multiple leg strategies, including spreads, will incur multiple transaction costs.

IBKR Campus Newsletters

This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.